Jenna A. Bosco

Statistics

Publications

Citations

314

H-Index

Active since

2020

Affiliations

Central Texas Neurology Consultants(Current)

CDG Therapeutics (United States)

Jenna A. Bosco is an author at Central Texas Neurology Consultants specializing in antibody-dependent cellular cytotoxicity, b-cell responses, and immunotherapy.

Publications per year

2020–2022

Publications

Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis

Lawrence Steinman, Edward Fox, Hans‐Peter Hartung et al. · New England Journal of Medicine · 2022 · 199 citations

Life Sciences, Immunology, Pharmacotherapy +17

A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis

Edward Fox, Amy E. Lovett‐Racke, Matthew Gormley et al. · Multiple Sclerosis Journal · 2020 · 115 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

1–2 of 2